Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intradermal grass pollen immunotherapy for seasonal allergic rhinitis
2012-002193-31Phase 4Completed
- Sponsor
- King's College London
- Start
- Jul 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of alutard phleum pratense in seasonal allergic rhinitis (SAR) (2 arms), sponsored by King's College London. Primary endpoint: Combined symptom and medication score. Started Jul 2012; status: completed.
02
Drugs
alutard phleum pratense
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2012-002193-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002193-31.